Martin is an accomplished professional with extensive experience in bioanalysis and mass spectrometry. Currently serving as the Director of Bioanalysis at Inoviv, Martin brings a wealth of knowledge and expertise to his role. Prior to joining Inoviv, Martin served as Lead Scientist at Medicines Discovery Catapult, where he established a high-throughput mass spectrometry laboratory and played a key role in developing innovative solutions for complex analytical challenges in drug discovery and biomarker research. Martin also contributed to innovative projects as a Postdoctoral Scientist at AstraZeneca, where he played a pivotal role in the design and development of Acoustic Mist Ionisation MS (AMI-MS), a cutting-edge analytical platform that revolutionized drug discovery efforts.